Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding

Sponsor
University of Southern California (Other)
Overall Status
Terminated
CT.gov ID
NCT01031342
Collaborator
(none)
72
1
2
87
0.8

Study Details

Study Description

Brief Summary

Study hypothesis is that performing early colonoscopy in patients who present to the hospital with lower GI bleeding improves their outcome.

Patients who are admitted with bleeding from their rectum and a negative endoscopic exam of the stomach and upper intestine are randomized (like flipping a coin) to receive a colonsoscopy either as an emergency (within 12 hours) or as a routine procedure (36 hours after admission). Patients are followed during their hospitalization to see if they have further bleeding, if they require blood transfusions, if they need other diagnostic tests, if they need surgery or other treatments, and how long they stay in the hospital.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Early colonoscopy
  • Procedure: Elective colonoscopy
N/A

Detailed Description

The aim of this study is to determine if performing early colonoscopy in patients who present to the hospital with lower GI bleeding improves their outcome.

Patients who are admitted with bleeding from their rectum and clinical evidence of a significant bleeding episode (elevated heart rate, low blood pressure, or need for blood transfusion) have immediate upper endoscopy (examination of the stomach with a flexible rubber tube with a light and video camera on the end). If this shows no source of bleeding, the patients are randomized (like flipping a coin) to receive a colonsoscopy (examination of the large intestine with a flexible rubber tube with a light and video camera on the end) either as a emergency (within 12 hours) or as a routine procedure (36 hours after admission).

Patients are followed during their hospitalization to see if they have further bleeding, if they require blood transfusions, if they need other diagnostic tests, if they need surgery or other treatments, and how long they stay in the hospital.

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Early Versus Elective Colonoscopy in the Management of Lower Gastrointestinal Bleeding
Study Start Date :
Aug 1, 2002
Actual Primary Completion Date :
Nov 1, 2009
Actual Study Completion Date :
Nov 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early colonoscopy

Colonoscopy performed within 12 hours of presentation

Procedure: Early colonoscopy
Colonoscopy within 12 hours of presentation

Active Comparator: Elective colonoscopy

Colonoscopy 36-60 hours after presentation

Procedure: Elective colonoscopy
Colonoscopy 36-60 hours after presentation

Outcome Measures

Primary Outcome Measures

  1. Further bleeding [Duration of hospitalization (randomization to date of discharge from hospital)]

Secondary Outcome Measures

  1. Diagnostic yield [Duration of hospitalization (randomization to date of discharge from hospital)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Patients who are admitted with rectal bleeding and one of the following high-risk features:
  1. HR > 100/min

  2. Systolic blood pressure <100 mmHg

  3. Orthostasis -considered as increase in HR by> 20/min on assuming erect position as well as by decrease by 20 mmHg in systolic blood pressure

  4. Need for blood transfusion

  5. Drop in hemoglobin > 1.5 g/dl or in hematocrit of > 6% in 6 hours

Exclusion Criteria:
  1. Inability to give informed consent

  2. Peritoneal signs

  3. Severe co-morbidities that would preclude the use of colonoscopy in standard clinical practice

Contacts and Locations

Locations

Site City State Country Postal Code
1 L.A. County + U.S.C. Medical Center Los Angeles California United States 90033

Sponsors and Collaborators

  • University of Southern California

Investigators

  • Principal Investigator: Loren Laine, M.D., University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01031342
Other Study ID Numbers:
  • HS-025014
First Posted:
Dec 14, 2009
Last Update Posted:
Jan 25, 2011
Last Verified:
Jan 1, 2011
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2011